Research Labs

Share
and/or
188 Faculty Members found
Molecular Biology Program
Andrew Koff, PhD
Molecular biologist Andrew Koff is interested in identifying the genes and and molecular mechanisms by which cells make decisions regarding their proliferative capacity after they exit from the cell cycle during therapy induced senescence and during normal development.
Molecular Pharmacology Program
Richard Kolesnick Lab Group
Richard N. Kolesnick, MD
Physician-scientist Richard Kolesnick studies the role of ceramide signaling in radiation-induced vascular dysfunction and tumor regression.
Department of Radiology
Simone Krebs, MD, MS
I am a physician-scientist whose work is focused on the development of imaging and theranostic agents including in vivo tracking methods of adoptively transferred cells for cancer therapy.
Memorial Hospital Research Laboratories
Human Oncology & Pathogenesis Program
Ladanyi lab
Marc Ladanyi, MD
Molecular pathologist Marc Ladanyi studies the molecular pathogenesis of sarcomas, lung cancer, and mesothelioma.
Developmental Biology Program
The Eric Lai Lab
Eric C. Lai, PhD
The Lai laboratory integrates genetics, biochemistry, and genomewide approaches to study diverse regulatory networks during patterning and behavior.
Computational & Systems Biology Program
Caleb Lareau, PhD
The Lareau Lab synthesizes computational and experimental genomics methods to study how immune cells in our bodies adapt, expand, differentiate, and evolve over an individual’s lifetime.
Developmental Biology Program
Joo-Hyeon Lee, PhD
The Lee laboratory studies the mechanisms governing homeostatic turnover and reparative programs in stem cells, with a focus on elucidating how tissue perturbations lead to lung disease.
Computational & Systems Biology Program
Christina Leslie, PhD
Computational biologist Christina Leslie focuses on developing machine learning algorithms for computational and systems biology.
Human Oncology & Pathogenesis Program
The Levine Lab
Ross L. Levine, MD
Mechanisms of genetic and epigenetic cooperativity which drive myeloid transformation; Elucidating and modeling evolution from hematopoietic stem/progenitor cells to clonal hematopoiesis and then to myeloid malignancies; Identification and credentialing novel therapeutic dependencies in myeloid malignancies